백민준 (KAIST)님 | 한빛사연구자 > 한빛사

KAIST

최종업데이트 2025.08.06.

Tumor-responsive mitochondria-targeted DON prodrugs for selective glutamine metabolism inhibition
- Chem. Eng. J., Available online 28 August 2026 | https://doi.org/10.1016/j.cej.2026.181296
- 2026-08
- 의약학
- 한빛사논문
Design Considerations for Organ-Selective Nanoparticles
- ACS Nano, Apr 22 2025, 19 (15) | https://doi.org/10.1021/acsnano.5c00484
- 2025-04
- 바이오·의료융합
- 한빛사논문
Photobleaching-mediated charge-convertible cyclodextrin nanoparticles achieve deep tumour penetration for rectal cancer theranostics
- Nat. Nanotechnol., 21 August 2024 | https://doi.org/10.1038/s41565-024-01757-4
- 2024-08
- 바이오·의료융합
- 한빛사논문
Tailoring renal-clearable zwitterionic cyclodextrin for colorectal cancer-selective drug delivery.
- Nat. Nanotechnol., Aug 2023, 18 (8) | https://doi.org/10.1038/s41565-023-01381-8
- 2023-08
- 바이오·의료융합
- 한빛사논문
Bentonite as a water-insoluble amorphous solid dispersion matrix for enhancing oral bioavailability of poorly water-soluble drugs.
- J. Control. Release, Oct 03 2023, S0168-3659(23)00650-8 | https://doi.org/10.1016/j.jconrel.2023.09.051
- 2023-10
- 의약학
- 한빛사논문

연구자 ID

저자논문